
Haleon plc
HLN
Updated: 22/09/2026, 17:41:10
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
No summaries found.
- Share price
- $9.28
- Market cap
- $40.85B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Brian James McNamara
- Employees
- 24,535
- IPO date
- 25/07/2022
- Beta
- 0.245
- Last dividend
- $0.00
- Day range
- $9.26 – $9.39
- 52-week range
- $8.65 – $11.28
- 1-day performance
- -0.91%
- 1-year performance
- 7.23%
- Current drawdown (1Y)
- -17.77%
- CIK
- 0001900304
- CUSIP
- 405552100
- ISIN
- US4055521003
- Created
- 07/12/2025, 04:33:15
- Last update
- 22/09/2026, 17:41:10
Track Haleon plc with an AI analyst
See which prediction-market events move HLN, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Haleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct.
Business Wire • STOCK • 04/06/2026, 16:32:00
Haleon plc (HLN) Presents at 23rd annual dbAccess Global Consumer Conference Transcript
Seeking Alpha • STOCK • 03/06/2026, 15:32:03
Haleon plc (HLN) Q1 2026 Sales/Trading Call Transcript
Seeking Alpha • STOCK • 29/04/2026, 11:02:49
Reckitt Benckiser vs Haleon: which is set up best for coming results?
Proactive Investors • STOCK • 31/03/2026, 12:49:29
Haleon set for slow start from weak flu season, with Middle East cushion
Proactive Investors • STOCK • 30/03/2026, 13:28:13
Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health
Business Wire • STOCK • 11/03/2026, 06:00:00
Haleon makes oral-health push in China as other Western brands falter
Reuters • STOCK • 10/03/2026, 20:03:04
Haleon PLC Sponsored ADR (HLN) Moves to Buy: Rationale Behind the Upgrade
Zacks Investment Research • STOCK • 26/02/2026, 14:00:53
Haleon's weaker sales make mid-term targets 'not look credible'
Proactive Investors • STOCK • 26/02/2026, 09:48:03
Haleon plc (NYSE:HLN) Reports Q4 Earnings: A Mixed Bag with Strong EPS but Slight Revenue Miss
Market Data • Market Data • 26/02/2026, 06:06:48
Haleon plc (HLN) Q4 2025 Earnings Call Prepared Remarks Transcript
Seeking Alpha • STOCK • 25/02/2026, 15:07:49
Haleon plc (HLN) Q4 2025 Earnings Call Transcript
Seeking Alpha • STOCK • 25/02/2026, 12:17:57